Name: CHU Xianming
Subject: Cardiology & Vascular Biology
Tel: +86-532-82913257
Email: chuxianming@qdu.edu.cn
Address: The Affiliated Hospital of Qingdao University, No. 59 Haier
Road; The Affiliated Cardiovascular Hospital of Qingdao
University, No. 5 Zhiquan Road, Qingdao
Resume:
CHU Xianming, Ph.D., is a professor in cardiology, and is now the Vice President of the Affiliated Cardiovascular Hospital of Qingdao University and the Vice Director of Cardiology Department of the Affiliated Hospital of Qingdao University. He is also the National Committee Member of Chinese Society of Electrocardiography and Vice Chairman of Pacing Electrocardiogram Working Committee of Chinese Electrocardiology Society. Professor CHU is interested in the regulation of vascular endothelial cell function, the programmed cell death (apoptosis, pyroptosis and ferroptosis) of cardiomyocytes, noncoding RNAs in the repair of cardiomyocytes and therapeutic effect of mesenchymal stem cell. He is also dedicated to exploring the mechanisms of various cardiovascular diseases and promoting the application of exosomes derived from stem cells for the diagnosis and therapy of anthracyclines-induced cardiotoxicity. He has published many significant academic achievements and applied several National Natural Science Foundations of China successfully. Professor CHU has been awarded as the Excellent Expert in Cardiac Electrophysiology and Pacing by the Chinese Heart Rhythm Society, Outstanding Young Interventional Physician by Chinese Medical Doctor Association and Excellent Doctor of Shandong Province by Shandong Medical Association.
Research Interests:
Professor CHU is interested in the Basic and clinical studies on the function regulation of vascular endothelial cells and repair of myocardial cell injury.
Recent Publications (corresponding author in three years):
1．Li Daisong., Yang Yanyan., Wang Shizhong., He Xiangqin., Liu Meixin., Bai Baochen., Tian Chao., Sun Ruicong., Yu Tao*., Chu Xianming*. (2021). Role of acetylation in doxorubicin-induced cardiotoxicity. Redox Biol, 46, 102089. doi:10.1016/j.redox.2021.102089. (JCR Q1, IF=11.788)
2．Wu Qinchao., Bai Baochen., Tian Chao., Li Daisong., Yu Haichu., Song Bingxue., Li Bing*., Chu Xianming*. (2021). The Molecular Mechanisms of Cardiotoxicity Induced by HER2, VEGF, and Tyrosine Kinase Inhibitors: an Updated Review. Cardiovasc Drugs Ther. doi:10.1007/s10557-021-07181-3. (JCR Q1, IF=4.069)
3．Tian Chao., Yang Yanyan., Bai Baochen., Wang Shizhong., Liu Meixin., Sun Rui-Cong., Yu Tao*., Chu Xianming*. (2021). Potential of exosomes as diagnostic biomarkers and therapeutic carriers for doxorubicin-induced cardiotoxicity. Int J Biol Sci, 17(5), 1328-1338. doi:10.7150/ijbs.58786. (JCR Q1, IF=6.58)
4．Bai Baochen., Yang Yanyan., Ji Shengxiang., Wang Shizhong., Peng Xingang., Tian Chao., Sun Rui-Cong., Yu Tao*., Chu Xianming*. (2021). MicroRNA-302c-3p inhibits endothelial cell pyroptosis via directly targeting NOD-, LRR- and pyrin domain-containing protein 3 in atherosclerosis. J Cell Mol Med, 25(9), 4373-4386. doi:10.1111/jcmm.16500. (JCR Q2, IF=5.31)
5．Bai Baochen., Yang Yanyan., Wang Qi., Li Min., Tian Chao., Liu Yan., Aung Lynn Htet Htet., Li Pei-Feng., Yu Tao*., Chu Xianming*. (2020). NLRP3 inflammasome in endothelial dysfunction. Cell Death Dis, 11(9), 776. doi:10.1038/s41419-020-02985-x. (JCR Q1, IF=8.469)
6．Wang Qi., Liu Bingyan., Wang Yuanyong., Bai Baochen., Yu Tao*., Chu Xianming*.(2020). The biomarkers of key miRNAs and target genes associated with acute myocardial infarction. PeerJ, 8, e9129. doi:10.7717/peerj.9129. (JCR Q2, IF=2.984)
7．Wang Qi., Yang Yanyan., Fu Xiuxiu., Wang Zhibin., Liu Yan., Li Min., Zhang Yinfeng., Li Yonghong., Li Pei-Feng., Yu Tao*., Chu Xianming*. (2020). Long noncoding RNA XXYLT1-AS2 regulates proliferation and adhesion by targeting the RNA binding protein FUS in HUVEC. Atherosclerosis, 298, 58-69. doi:10.1016/j.atherosclerosis.2020.02.018. (JCR Q1, IF=5.162)
